PHARMATHENE, INC

Profile

Company Names

PHARMATHENE, INC

Addresses

ONE PARK PLACE, SUITE 450, ANNAPOLIS, MD 21401

ONE PARK PLACE, SUITE 450, ANNAPOLIS, MD 21401

Phone Numbers

410 269 2600
(410) 269-2600

 

Entity Type:

CORPORATION

Industry:

OTHER, PHARMACEUTICALS

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$29,190,988.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2010-11-03 
$9,895,186.00 
$22,558,299.00 
$12,663,113.00 
Equity 
1
2009-07-28 
$19,295,802.00 
$19,295,802.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPHER 
C. 
CAMUT 
EXECUTIVE OFFICER
PHARMATHENE, INC
JAMES 
H. 
CAVANAUGH 
DIRECTOR
PHARMATHENE, INC   |  VERENIUM CORP
FRANCESCA 
 
COOK 
EXECUTIVE OFFICER
PHARMATHENE, INC
THOMAS 
R. 
FUERST 
EXECUTIVE OFFICER
PHARMATHENE, INC
JOAN 
 
FUSCO 
EXECUTIVE OFFICER
PHARMATHENE, INC
JOHN 
 
GILL 
DIRECTOR
PHARMATHENE, INC   |  DOOLEY-S PETROLEUM, INC.   |  DOOLEY BROS LLP   |  DOOLEY-S NATURAL GAS, LLC   |  DOOLEY-S NATURAL GAS II, LLC   |  ALLIANCE MIDSTREAM LLC
JORDAN 
P. 
KARP 
EXECUTIVE OFFICER
PHARMATHENE, INC
JOEL 
 
MCCLEARY 
DIRECTOR
PHARMATHENE, INC   |  RAYDIANCE INC
WAYNE 
 
MORGES 
EXECUTIVE OFFICER
PHARMATHENE, INC
JOHN 
 
PAPPAJOHN 
DIRECTOR
PHARMATHENE, INC   |  SPECTRASCIENCE INC   |  CNS RESPONSE, INC.   |  CANCER GENETICS INC   |  GATE TECHNOLOGIES, LLC   |  ST. GREGORY CENTERS HOLDINGS, LLC   |  SYNCBAK, INC.   |  AMERICAN CARESOURCE HOLDINGS, INC.   |  MYND ANALYTICS, INC.   |  CANCER GENETICS, INC   |  CONNECTRN, INC.   |  INSEER INC.   |  ONERORX, INC.   |  TELEMYND, INC.
CHARLES 
A. 
REINHART III 
EXECUTIVE OFFICER
PHARMATHENE, INC
ERIC 
I. 
RICHMAN 
EXECUTIVE OFFICER, DIRECTOR
PHARMATHENE, INC   |  ADMA BIOLOGICS, INC.   |  GAIN THERAPEUTICS, INC.
VALERIE 
 
RIDDLE 
EXECUTIVE OFFICER
PHARMATHENE, INC
VALERIE 
C. 
RIDDLE 
EXECUTIVE OFFICER
PHARMATHENE, INC
JEFFREY 
W. 
RUNGE 
DIRECTOR
PHARMATHENE, INC   |  CAROLINA COMPLETE HEALTH NETWORK, INC.   |  ADITX THERAPEUTICS, INC.   |  ADITXT, INC.
MITCHEL 
 
SAYARE 
DIRECTOR
PHARMATHENE, INC   |  AUTOIVF, INC.
DERACE 
L. 
SCHAFFER 
DIRECTOR
PHARMATHENE, INC
STEVEN 
 
ST. PETER 
DIRECTOR
PHARMATHENE, INC   |  XANODYNE PHARMACEUTICALS INC   |  MPM BIOVENTURES V, L.P.   |  RHYTHM PHARMACEUTICALS, INC.   |  ARATANA THERAPEUTICS, INC.   |  PROTEON THERAPEUTICS INC
DAVID 
P. 
WRIGHT 
EXECUTIVE OFFICER, DIRECTOR
PHARMATHENE, INC   |  ACHILLION PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-11-19
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-11-03 
2009-08-12
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Debt 
2009-07-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#